Related Experiment Video
Updated: May 30, 2026

Dynamic Assessments of Coronary Flow Reserve after Myocardial Ischemia Reperfusion in Mice
Published on: August 25, 2023
[Metabolic issues of ischemia induced myocardial dysfunction]
Insights
Myocardial ischemia can cause heart dysfunction without cell death. Understanding new ischemic syndromes like preconditioning and stunning is key to protecting the heart from injury.
Area of Science:
- Cardiology
- Pathophysiology
- Molecular Biology
Context:
- Myocardial ischemia is a leading cause of heart failure, often manifesting as systolic and/or diastolic dysfunction.
- Cardiomyocyte necrosis and cardiosclerosis are traditional markers of ischemic damage.
- Emerging evidence suggests contractile dysfunction can be reversible, independent of cell death.
Purpose:
- To review the phenomenon of ischemic preconditioning, hibernation, and myocardial stunning.
- To explore the role of these 'new ischemic syndromes' in ischemia-induced myocardial dysfunction.
- To consider the less-known 'no-reflow' phenomenon as a type of myocardial stunning.
Summary:
- Myocardial ischemia, while often leading to cell death, can also cause reversible contractile dysfunction.
- Ischemic preconditioning, hibernation, and myocardial stunning are key phenomena influencing myocardial function post-ischemia.
- These syndromes highlight the heart's complex response to reduced blood flow and potential for recovery.
Impact:
- Understanding these syndromes is crucial for developing novel therapeutic strategies.
- Further research into the molecular mechanisms of ischemic syndromes can guide the development of cardioprotective treatments.
- This review emphasizes the need for new methods to protect the myocardium from ischemic and reperfusion injury.
Abstract:
Myocardial ischemia represents most common cause of necrosis of cardiomyocytes, cardio sclerosis and heart failure. Main clinical manifestation of myocardial ischemia is systolic and/or diastolic dysfunction. It has been shown, that local disturbance of myocardial contractility is not always determined by cell necrosis and cardio sclerosis, as improvement of coronary perfusion may lead to restoration of contractile function of myocardium. Present review outlines aspects of phenomenon of ischemic preconditioning, hibernation and myocardial stunning (so called new ischemic syndromes) that are suggested to be determinants of ischemia induced myocardial dysfunction. No-reflow (Less known type of myocardial stunning) is considered also. However, further studies of molecular mechanisms of ischemic syndromes are necessary for development of new methods of protection of myocardium against ischemic or reperfusion injury.
Related Concept Videos
Myocarditis I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Ischemic Stroke ll: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Cellular Injury IV: Necrosis
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...

![Investigating Cardiac Metabolism in the Isolated Perfused Mouse Heart with Hyperpolarized [1-13C]Pyruvate and 13C/31P NMR Spectroscopy](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F63188.jpg&w=3840&q=50)